X
Biogen bolsters ischaemic stroke pipeline with thrombolytic from TMS
https://pharmaphorum.com/news/biogen-bolsters-ischaemic-stroke-pipeline-with-thrombolytic-from-tms/
stroke
The future of stroke treatment
Stroke is a major cause of disability and death worldwide and the third most common cause of death in developed countries. Nearly six million people die from stroke every year and another five million are left permanently disabled.
Stroke prevention device wins healthtech award
Neuravi’s Embotrap II can clear blood clots responsible for stroke.
Virtual reality stroke rehab platform gets FDA clearance
MindMotion Pro helps with upper-limb rehabilitation following a stroke.
Biogen pays Remedy $120m to bolster stroke pipeline
Acquisition provides Biogen a fall back molecule in this high risk therapy area.
1 2